Home - Aquila Bioscience

Pathogen Capture Technology (PCT)

Human pathogens such as viruses, bacteria, and fungi, bind to proteins and sugar chains on our cell surfaces to establish an infection.

Aquila’s proprietary PCT uses biomolecules that mimic these glycoproteins to bind to the protein spikes on pathogens, capturing and neutralising them. These interactions are similar to Velcro®, a mechanism from which they cannot escape.

This technology is already being applied in the ABD Device and ProShield Mask Spray and our R&D teams continue to develop new products and applications.

Video Player

ABD DEVICE

The ABD wipe (Anti Bioagent Decontamination Device) uses pathogen capture technology to remove 99.99% of pathogens, including SARS-CoV-2 (COVID-19), from human skin. It can be applied safely and comfortably to sensitive areas like around the eyes, nose and mouth.

USA FDA

The product is a US FDA registered Class I medical device that comes in the form of a decontamination wipe.

PROSHIELD MASK SPRAY

ProShield Mask Spray™ converts simple cloth masks into a highly protective face coverings while helping the environment. ProShield Mask Spray contains no alcohol or toxic chemicals. Acting as an invisible shield on the reusable face mask, it prevents pathogens from entering the human airways.

Inspired by Nature. Excellence in Science

R&D

Aquila Bioscience is an innovative R&D company aiming to deliver disruptive technologies and sustainable solutions in carbohydrate based biology, and its applications in pathogen management.

References

Aquila Bioscience is heavily invested in scientific research and is busy discussing, presenting and writing about developments in green chemistry and glycoscience.

Next Gen Products

Carbohydrates (also called glycans) are universally present on every cell and are essential for cell-cell communication. Aquila Bioscience is at the forefront of applying glycoscience.

News/Media

Our mission is to protect the world’s health through developing technologically advanced and environmentally friendly products using nature based solutions.

Products

Aquila Bioscience creates innovative products free from alcohol, biocides and toxic chemicals and as so, do not cause skin irritation or destroy skin cells.

Shop

The team at Aquila Bioscience strives to make products 99.99% SARS-Cov-2 available that are the best on the market for safely protecting humans against ever-changing pathogens.

15

R&D Staff

200 M2

BioInnovation Space

€ 3.5 m

Research Funding

99 .99%

Effective Against SARS-CoV-2

Our products are shipped to clients globally.

MEDICAL RESEARCH 90%

BIOTECHNOLOGY 80%

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 959436

Website last updated in July 2024